Corporate News – Market Activity Update
Glaukos (ticker GKOS) closed its trading session up 3.88 % at 01:16 AM Central Europe on Thursday, 22 October 2026. The current trading price on major exchanges is USD 176.85 per share.
The company’s outstanding share supply stands at 58.9 million shares. With this supply, Glaukos’ market capitalization is USD 9.8 billion. In the last 24 hours, trading volume reached USD 106.5 million.
Since the end of last month, the stock has gained 7.37 %. The simple moving average over the preceding 200 days is USD 138.14. The highest price recorded in the past 52 weeks was USD 191.62 on 20 August 2026, while the lowest price was USD 73.16 on 28 October 2025.
Comparative Performance – Past 24 Hours
| Stock | 24‑hour Change | Current Price (USD) | Market Capitalization (USD) |
|---|---|---|---|
| Madison Air (MAIR) | +0.04 % | 23.22 | 11.6 billion |
| Generac (GNRC) | +0.67 % | 203.14 | 11.4 billion |
| HubSpot (HUBS) | +6.87 % | 249.90 | 11.7 billion |
| Elanco Animal Health (ELAN) | –3.36 % | 22.55 | 11.7 billion |
| Tempus AI (TEM) | +3.75 % | 67.76 | 11.6 billion |
Additional valuation metrics for the selected stocks are:
- Generac price‑to‑earnings ratio: 44.52
- HubSpot price‑to‑earnings ratio: 83.81
Company Overview
Glaukos Corporation is an ophthalmic medical‑technology firm within the healthcare sector, focused on medical devices for glaucoma treatment. The company designs, manufactures, and markets micro‑scale injectable therapies intended to address all stages of glaucoma disease progression. Glaukos was listed on the New York Stock Exchange following an IPO on 25 June 2015. For further information, visit the company’s website at www.glaukos.com .
